Alto Neuroscience ANRO
NYSE ANRO
$35.56 -0.84 (-2.31%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alto Neuroscience (ANRO) Debt Ratio (2023 - 2026)

Alto Neuroscience (ANRO) posted Debt Ratio of 0.06 for Q1 2026, down 36.08% sequentially from 0.09 in Q4 2025, and down 50.0% YoY from 0.12 in Q1 2025.

Analysis

Alto Neuroscience (ANRO) Debt Ratio (2023 - 2026) Analysis & Trends

Alto Neuroscience has reported Debt Ratio for 4 years, with the latest figure at 0.06 in Q1 2026.

  • Quarterly Debt Ratio fell 50.0% year-over-year to 0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06 (down 50.0% YoY) and the FY2025 annual result came in at 0.09, up 57.1% from the prior year.
  • Debt Ratio declined to 0.06 in Q1 2026 per ANRO's latest filing, from 0.09 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.14 in Q3 2025 and troughed at 0.05 in Q1 2024.
  • A 4-year average of 0.09 and a median of 0.08 in 2024 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2025 and 2026: Debt Ratio surged 119.24% in 2025, then tumbled 50.0% in 2026.
  • Over 4 years, Debt Ratio stood at 0.11 in 2023, then slumped by 49.26% to 0.06 in 2024, then surged by 57.1% to 0.09 in 2025, then sank by 36.08% to 0.06 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.06, 0.09, and 0.14 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.05
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.05
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.12
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.47
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.26
10 Alto Neuroscience 1.52 Bn 1.52 Bn - 0.06
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.06
Mar 31, 2026 0.06
Dec 31, 2025 0.09
Sep 30, 2025 0.14
Jun 30, 2025 0.13
Mar 31, 2025 0.12
Dec 31, 2024 0.06
Sep 30, 2024 0.07
Jun 30, 2024 0.06
Mar 31, 2024 0.05
Dec 31, 2023 0.11